Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update).
Grunfeld
Eva
E
Dalhousie University, Halifax, NS.
Dhesy-Thind
Sukhbinder
S
Levine
Mark
M
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D002170:Canada; D003072:Cognition Disorders / Q000139:chemically induced*; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D008991:Monitoring, Physiologic; D009483:Neuropsychological Tests; D010024:Osteoporosis / Q000209:etiology; D017410:Practice Guidelines as Topic; D011788:Quality of Life; D012307:Risk Factors; D012735:Sexual Dysfunction, Physiological / Q000209:etiology; D015430:Weight Gain
D000970:Antineoplastic Agents